Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02349061 |
|---|---|
| Brief Title: | A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus |
| First Submitted : | January 23, 2015 |
| First Submitted that Met QC Criteria : | January 23, 2015 |
| First Posted : | January 28, 2015 (Estimate) |
| Results First Submitted : | May 15, 2018 |
| Results First Submitted that Met QC Criteria : | May 15, 2018 |
| Results First Posted : | June 12, 2018 |
| Last Update Submitted that Met QC Criteria : | March 11, 2020 |
| Last Update Posted : | March 24, 2020 |